✦ LIBER ✦

Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years

✍ Scribed by Tino F. Schwarz; Marek Spaczynski; Achim Schneider; Jacek Wysocki; Andrzej Galaj; Pamela Perona; Sylviane Poncelet; Toufik Zahaf; Karin Hardt; Dominique Descamps; Gary Dubin

Book ID: 116961086
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 653 KB
Volume: 27
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2008.10.088

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and Safety of Human Papil

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years

✍ Tiina Petäjä; Heli Keränen; Tiina Karppa; Anna Kawa; Sirkku Lantela; Mari Siitar 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 414 KB

Immunogenicity and Safety of Human Papil

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04 Adjuvanted Vaccine in Healthy Males Aged 10–18 Years

✍ M. Lehtinen; T. Petäjä; H. Keränen; T. Karppa; A. Kawa; S. Lantela; H. Levänen; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Immunogenicity and safety of human papil

Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women

✍ Neerja Bhatla; Vanita Suri; Partha Basu; Surendra Shastri; Sanjoy K. Datta; Dan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 977 KB

Sustained efficacy and immunogenicity of

Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women

✍ N. De Carvalho; J. Teixeira; C.M. Roteli-Martins; P. Naud; P. De Borba; T. Zahaf 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 535 KB

Efficacy of the human papillomavirus (HP

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV-16/18

✍ A. Szarewski; W.A.J. Poppe; S.R. Skinner; C.M. Wheeler; J. Paavonen; P. Naud; J. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 857 KB

A review of cross-protection against onc

A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: Importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention

✍ David Jenkins 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 246 KB